Barclays PLC Takes Position in Myomo, Inc. (NYSEAMERICAN:MYO)

Barclays PLC purchased a new stake in Myomo, Inc. (NYSEAMERICAN:MYO) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 8,958 shares of the company’s stock, valued at approximately $36,000.

Other hedge funds have also added to or reduced their stakes in the company. Rosalind Advisors Inc. boosted its position in Myomo by 13.4% during the 3rd quarter. Rosalind Advisors Inc. now owns 3,021,391 shares of the company’s stock worth $12,116,000 after buying an additional 356,392 shares during the period. Herr Investment Group LLC raised its holdings in Myomo by 72.9% during the 2nd quarter. Herr Investment Group LLC now owns 2,846,071 shares of the company’s stock worth $9,136,000 after purchasing an additional 1,200,244 shares during the last quarter. Essex Investment Management Co. LLC raised its holdings in Myomo by 40.2% during the 3rd quarter. Essex Investment Management Co. LLC now owns 899,135 shares of the company’s stock worth $3,606,000 after purchasing an additional 257,749 shares during the last quarter. GSA Capital Partners LLP raised its holdings in Myomo by 60.8% during the 3rd quarter. GSA Capital Partners LLP now owns 103,342 shares of the company’s stock worth $414,000 after purchasing an additional 39,085 shares during the last quarter. Finally, Vontobel Holding Ltd. bought a new position in Myomo during the 3rd quarter worth approximately $90,000. 44.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

MYO has been the subject of several research analyst reports. Ascendiant Capital Markets lifted their price objective on shares of Myomo from $8.50 to $9.00 and gave the company a “buy” rating in a research note on Tuesday, November 12th. HC Wainwright reiterated a “buy” rating and issued a $7.50 price objective on shares of Myomo in a research note on Wednesday, November 13th. Finally, Craig Hallum lifted their price objective on shares of Myomo from $7.00 to $9.00 and gave the company a “buy” rating in a research note on Friday, December 13th.

Myomo Trading Down 5.9 %

Shares of NYSEAMERICAN:MYO opened at $6.51 on Friday. The stock has a market capitalization of $196.93 million, a P/E ratio of -28.30 and a beta of 1.71. Myomo, Inc. has a fifty-two week low of $2.51 and a fifty-two week high of $7.17.

Myomo (NYSEAMERICAN:MYO) last released its quarterly earnings data on Wednesday, November 6th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.01. The business had revenue of $9.21 million for the quarter, compared to the consensus estimate of $7.95 million. Myomo had a negative net margin of 33.22% and a negative return on equity of 86.30%. On average, analysts expect that Myomo, Inc. will post -0.19 EPS for the current year.

About Myomo

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.